Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02421692 · ClinicalTrials.gov registry record · NA

Improving Physical Function in Skilled Nursing Facility Residents

A NA study, sponsored by University of Colorado, Denver.

Terminated
Registry status
NA
Development phase
153
Enrollment target

NCT02421692: Clinical Trial NA study, sponsored by University of Colorado, Denver.

NCT02421692 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02421692, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.

TERMINATED
Registry status
NA
Development phase
153 participants
Enrollment target

Study Summary

Each year Medicare spends approximately $31.3 billion on 2.4 million skilled nursing facility (SNF) episodes of care. SNFs rely on interdisciplinary approaches to patient care to maximize rehabilitation potential for return to prior level of function and reduce the risk of adverse events in older adults. However despite a substantial increase in spending on SNF services and minimal change in complexity of the caseload, 68% of patients are below their pre-hospitalization level of function at discharge, 25% return to the community, and 18% are hospitalized. This may be partially explained by current SNF approaches to patient care which foster inactivity and participation in low intensity rehabilitation interventions (preliminary data). Both inactivity and low-intensity interventions may perpetuate further functional decline or impede maximal recovery. The serious implication of risk with functional decline is exemplified by studies which have shown declines in physical function can increase the risk of being re-hospitalized six-fold and may infer other long term effects such as increased risk for mortality, morbidity, and institutionalization. Muscle weakness, reduced cardiorespiratory reserve, and neuromuscular deficits have been attributed to this acute decline in function. However current rehabilitation strategies in SNFs do not promote adequate dose and mode of interventions to induce beneficial systemic adaptations, perhaps due to the lack of evidence on effective rehabilitation protocols for this medically-complex population. Therefore, the investigators have designed an rehabilitation program, which uniquely integrates principles of physiologic tissue overload with strengthening and functional interventions for greater gains in physical function. Data will be collected on the first cohort of patients who cycle through a SNF during Stage 1, in which usual care occurs (5 months). Then, staff training on progressive rehabilitation interventions will occur over 2 m

Primary Outcome

Global measure of lower extremity function, which consists of walking speed, chair stands, and balance tests

Interventions

  • OTHER Progressive Rehabilitation

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2015-04
Est. Completion 2016-11
Phase NA
University of Colorado, Denver

1,283 total trials

Why NCT02421692 stopped before completion

NCT02421692 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Progressive Rehabilitation is the first listed.

NCT02421692 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02421692 about?

NCT02421692 is a clinical study titled "Improving Physical Function in Skilled Nursing Facility Residents". Each year Medicare spends approximately $31.3 billion on 2.4 million skilled nursing facility (SNF) episodes of care. SNFs rely on interdisciplinary approaches to patient care to maximize rehabilitation potential for return to prior level of function and reduce the risk of adverse events in older ad...

What is the current status of trial NCT02421692?

This trial is currently terminated. It is a NA study. The enrollment target is 153 participants. The study started on 2015-04. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02421692?

The interventions under investigation include: Progressive Rehabilitation (OTHER).

Who is sponsoring clinical trial NCT02421692?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02421692's enrollment target sits among peer trials

153 656th of 2000 higher than 1,343 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283265 · 153 participants · NA

    Neurophysiological Mechanisms of Language Comprehension

  • NCT05554393 · 153 participants · Phase 2

    Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • NCT05584501 · 153 participants · NA

    ETE Interventions in the Dental Setting

  • NCT05714839 · 153 participants · Phase 1

    A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02421692, the US trial registry maintained by the National Library of Medicine. NCT02421692 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.